Mylan on Wednesday launched its celecoxib capsules in 50-, 100-, 200- and 400-mg dosage strengths. The drug is one of the first available generic versions of Celebrex capsules from Pfizer.
Greenstone announced the introduction of cabergoline tablets to its line of pharmaceutical products.
Camber Pharmaceuticals announced the addition of montelukast sodium tablets to its portfolio of products.
Mylan on Thursday announced that its subsidiary, Mylan Labs, was granted tentative approval from the Food and Drug Administration for two dosages of abacavir/lamivudine tablets for oral suspension.
Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.
Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.
Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.
Reynolds American on Thursday will be sharing information on the national launch of Zonnic, a smoking cessation gum marketed by the company's subsidiary Niconovum USA.
Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.
Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.